EurekAlert!

Modeling spinal muscular atrophy to identify a promising therapy

Spinal muscular atrophy (SMA) is a rare but serious neuromuscular disorder that causes worsening muscle weakness. SMA is a genetic, or inherited, disorder caused by a change in the SMN1 gene that ...
Forbes

New Gene Therapy Possible For Infants With Spinal Muscular Atrophy

Forbes contributors publish independent expert analyses and insights. Spinal muscular atrophy affects the nerves that control muscle movement, leading to progressive weakening. As a result, infants ...
Business Wire

Exegenesis Bio to Present 9-Patient Data from a Phase 1/2 Clinical Trial of EXG001-037, a Novel rAAV Gene Therapy for Spinal Muscular Atrophy (SMA) Type 1: Improved Head ...

PHILADELPHIA--(BUSINESS WIRE)--Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of clinical efficacy and safety data from its EXG001-307 ...
BMJ

501 EP041 – Heat therapy during immobilization and rehabilitation: a proactive approach to preventing muscle atrophy and strength loss upon return to sport

Skeletal muscle immobilization has been demonstrated to induce atrophy and strength loss. Research utilizing animal models posits that the application of heat therapy may serve as a protective ...